Paper20161667
Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress.
Silverstein RL. Clin Lipidol, 2009. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress. Papers, record 20161667. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20161667
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 HL087018 | NHLBI NIH HHS | United States | P01HL087018 | PubMed and NIH | NIH RePORTER |
| P50 HL081011 | NHLBI NIH HHS | United States | P50HL081011 | PubMed and NIH | NIH RePORTER |
References149
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11927940 | Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. | Nat Med | 2002 | https://conductscience.org/library/papers/11927940 | PubMed |
| 2 | 16728653 | Scavenger receptors in atherosclerosis: beyond lipid uptake. | Arterioscler Thromb Vasc Biol | 2006 | https://conductscience.org/library/papers/16728653 | PubMed |
| 3 | 9419208 | Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva. | J Exp Med | 1998 | https://conductscience.org/library/papers/9419208 | PubMed |
| 4 | 14512369 | Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1. | Arterioscler Thromb Vasc Biol | 2003 | https://conductscience.org/library/papers/14512369 | PubMed |
| 5 | 15486305 | Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. | Arterioscler Thromb Vasc Biol | 2004 | https://conductscience.org/library/papers/15486305 | PubMed |
| 6 | 16148537 | Scavenger receptors: friend or foe in atherosclerosis? | Curr Opin Lipidol | 2005 | https://conductscience.org/library/papers/16148537 | PubMed |
| 7 | 7536797 | CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. | J Exp Med | 1995 | https://conductscience.org/library/papers/7536797 | PubMed |
| 8 | 16061696 | Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. | J Cell Biol | 2005 | https://conductscience.org/library/papers/16061696 | PubMed |
| 9 | 19176395 | Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism. | Cancer Res | 2009 | https://conductscience.org/library/papers/19176395 | PubMed |
| 10 | 16920954 | Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. | J Immunol | 2006 | https://conductscience.org/library/papers/16920954 | PubMed |
| 11 | 10328956 | Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1. | Exp Cell Res | 1999 | https://conductscience.org/library/papers/10328956 | PubMed |
| 12 | 18653762 | SNMP is a signaling component required for pheromone sensitivity in Drosophila. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18653762 | PubMed |
| 13 | 8838662 | CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium. | J Cell Sci | 1996 | https://conductscience.org/library/papers/8838662 | PubMed |
| 14 | 16919281 | Continued inhibition of atherosclerotic lesion development in long term Western diet fed CD36o /apoEo mice . | Atherosclerosis | 2007 | https://conductscience.org/library/papers/16919281 | PubMed |
| 15 | 10938017 | Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. | Arterioscler Thromb Vasc Biol | 2000 | https://conductscience.org/library/papers/10938017 | PubMed |
| 16 | 10772654 | Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. | J Clin Invest | 2000 | https://conductscience.org/library/papers/10772654 | PubMed |
| 17 | 11433350 | A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation. | Nat Med | 2001 | https://conductscience.org/library/papers/11433350 | PubMed |
| 18 | 10198299 | Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36. | Am J Physiol | 1999 | https://conductscience.org/library/papers/10198299 | PubMed |
| 19 | 12796750 | High levels of circulating endothelial microparticles in patients with acute coronary syndromes. | Am Heart J | 2003 | https://conductscience.org/library/papers/12796750 | PubMed |
| 20 | 2435757 | Isolation of the thrombospondin membrane receptor. | J Clin Invest | 1987 | https://conductscience.org/library/papers/2435757 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40990667 | CD36 serves as a signaling receptor and free fatty acid (FFA) transporter in dyslipidemia: the role of dapagliflozin and alirocumab in downregulating atherogenic dyslipidemia via FFA uptake inhibition-experimental study. | Int J Surg | 2026 | https://conductscience.org/library/papers/40990667 | PubMed |
| 39674882 | Regulation of lipid storage and inflammation in the liver by CEACAM1. | Eur J Clin Invest | 2024 | https://conductscience.org/library/papers/39674882 | PubMed |
| 39057711 | The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies. | Metabolites | 2024 | https://conductscience.org/library/papers/39057711 | PubMed |
| 38267700 | PDL-1 and insulin resistance in obesity: a possible pathway for macrovascular disease. | Hum Cell | 2024 | https://conductscience.org/library/papers/38267700 | PubMed |
| 38069209 | Expression of Tissue Factor and Platelet/Leukocyte Markers on Extracellular Vesicles Reflect Platelet-Leukocyte Interaction in Severe COVID-19. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38069209 | PubMed |
| 35795725 | Thrombosis and Anticoagulation Therapy in Systemic Lupus Erythematosus. | Autoimmune Dis | 2022 | https://conductscience.org/library/papers/35795725 | PubMed |
| 34535958 | Human Placental Mesenchymal Stem/Stromal cells (pMSCs) inhibit agonist-induced platelet functions reducing atherosclerosis and thrombosis phenotypes. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/34535958 | PubMed |
| 33437358 | Endothelial cell CD36 deficiency prevents normal angiogenesis and vascular repair. | Am J Transl Res | 2020 | https://conductscience.org/library/papers/33437358 | PubMed |
| 30235742 | Correlation of gene polymorphisms of CD36 and ApoE with susceptibility of Alzheimer disease: A case-control study. | Medicine (Baltimore) | 2018 | https://conductscience.org/library/papers/30235742 | PubMed |
| 23233532 | CD36-dependent signaling mediates fatty acid-induced gut release of secretin and cholecystokinin. | FASEB J | 2013 | https://conductscience.org/library/papers/23233532 | PubMed |
| 22715334 | The Pathogenic Role of the Adaptive Immune Response to Modified LDL in Diabetes. | Front Endocrinol (Lausanne) | 2012 | https://conductscience.org/library/papers/22715334 | PubMed |
| 22275803 | The association of CD36 variants with polypoidal choroidal vasculopathy compared to typical neovascular age-related macular degeneration. | Mol Vis | 2012 | https://conductscience.org/library/papers/22275803 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20161667
GET https://conductscience.org/api/papers/v1/20161667/references?page=2